LSH: 8-K · offering registration
Quanome Technologies, Inc. entered into an At The Market Offering Agreement with Maxim Group LLC on October 21, 2026, allowing it to sell up to $9,754,475 of common stock from time to time at prevailing market prices. Sales are made under the company's Form S-3 shelf (File No. 333-297324), declared effective October 16, 2026, with Maxim earning a 3.0% commission on gross sales plus expense reimbursements capped at $40,000. There is no minimum offering amount, so actual proceeds and dilution are not yet determinable. Proceeds are earmarked for working capital, general corporate purposes, business development, and potential acquisitions. As a micro-cap emerging growth company, the ATM program provides flexible funding but introduces ongoing dilution risk whenever shares are sold.
LSH: 424B5 · prospectus supplement
Quanome Technologies (formerly Lakeside Holding Limited; Nasdaq: QNME) filed a 424B5 on October 21, 2026 establishing an at-the-market offering of up to $9,754,475 of common stock (up to 20,579,061 shares at the assumed $0.474 price) through Maxim Group LLC as sales agent, earning up to a 3% commission. If fully sold, shares outstanding would rise from 34,427,559 to 55,006,620 — roughly 60% dilution versus the ~$29.3M public float — with new investors facing immediate dilution of $0.18 per share versus the $0.20 June 30, 2026 net tangible book value. Proceeds are earmarked for working capital, general corporate purposes, and potential acquisitions. The filing also discloses the company is in a second 180-day Nasdaq bid-price compliance period (deadline January 4, 2027) with a possible reverse split contemplated, alongside extensive PRC regulatory risks around its Hupan Pharmaceutical distribution business and early-stage, pre-revenue AI compute and quantum subsidiaries.
LSH: 8-K · material agreement
Quanome Technologies' subsidiary XDT Infrastructure I, LLC signed its first enterprise customer agreement, a Master Services Agreement with an initial 60-month order carrying a total commitment value exceeding $100 million for dedicated AI inference capacity. Service is expected to commence within approximately two months, subject to service-start conditions, meaning revenue recognition has not yet begun and remains contingent on contract conditions and infrastructure deployment. Separately, Quanome agreed to purchase 32 additional GPU server units for approximately US$18.8 million, to be delivered to a U.S. data center. The deal marks the company's transition from planned infrastructure deployment toward long-term, recurring managed-services revenue, though execution and delivery risks remain.
Lakeside (NASDAQ:LSH) versus Air T (NASDAQ:AIRT) Head-To-Head Comparison
Quanome Technologies entered into Purchase Agreement No. 2 with Compal Electronics on September 29, 2026 to buy 32 additional GPU server units for approximately US$18.8 million, with a 20% down payment and the remaining 80% due before shipment. The same day, its subsidiary XDT Infrastructure I, LLC signed a 60-month Token Factory Master Services Agreement with XPERT SOFTWARE SOLUTIONS PTE. LTD. providing dedicated AI inference capacity on NVIDIA infrastructure, with approximately $100.9 million in aggregate committed fees payable as a fixed monthly fee. The customer will prepay roughly $45.0 million in two tranches tied to server procurement milestones, substantially funding the dedicated build-out; no prepayment has yet become due or been paid. The contracts remain subject to delivery, payment, and regulatory supply-chain conditions, and full agreement texts are expected as exhibits to the Q3 2026 Form 10-Q.
Reviewing Lakeside (NASDAQ:LSH) and FedEx (NYSE:FDX)
LSH: 8-K · debt financing
Quanome Technologies (Nasdaq: QNME) entered a revolving loan agreement on September 28, 2026 with its own Chairman and CEO Yang Li, allowing up to $15.0 million in outstanding advances at 6.0% annual interest for working capital and general corporate purposes. The facility is non-dilutive and revolving, but each advance requires the lender's written approval, the lender may cut off further advances at any time, and the agreement matures just three months after its effective date. If Mr. Li stops serving as both Chairman and CEO, all outstanding amounts are due within 30 days. The Audit Committee of three independent directors independently reviewed and approved the related-party transaction, with Mr. Li recusing himself. The filing frames the facility as insider confidence in Quanome's quantum computing strategy, though the short tenor and discretionary draws limit how dependable this capital source is.
LSH: S-3/A · shelf registration
Quanome Technologies (formerly Lakeside Holding Limited, prior ticker LSH, now QNME) filed Pre-Effective Amendment No. 3 to its Form S-3 shelf registration to offer up to $120,000,000 of common stock, preferred stock, debt securities, warrants, rights and units from time to time. Sales are capped by the Baby Shelf Limitation at one-third of its roughly $29.3 million public float per 12 months while the float stays below $75 million. The filing discloses the company remains out of compliance with Nasdaq's $1.00 minimum bid price and has until January 4, 2027 to cure, potentially via a reverse stock split. Its stock closed at $0.54 on September 30, 2026, against a 52-week range of $0.2504 to $1.68. Substantially all revenue now comes from PRC pharmaceutical distribution subsidiary Hupan Pharmaceutical after the February 2026 disposal of its U.S. logistics business, while new quantum and AI compute initiatives (via Quantum Nexus and XDT) remain pre-revenue. Extensive PRC regulatory, CSRC filing, and HFCAA risk disclosures accompany the shelf.
LSH: 10-K · periodic report
Quanome Technologies, Inc. (formerly Lakeside Holding Limited, which traded as LSH) filed its FY2026 10-K as a Nevada holding company whose continuing business is pharmaceutical distribution in China through subsidiary Hupan Pharmaceutical. The company transferred its ABL Chicago logistics operations to a third party on February 12, 2026, and changed its name and ticker to QNME on Nasdaq effective August 4, 2026. The company is pursuing two unrevenueed new ventures: quantum-related technologies through Quantum Nexus, and AI compute capacity and managed inference services through XDT Infrastructure I, LLC, which began operations in September 2026 and has an agreement to purchase 32 AI servers but no executed customer contracts. Its only revenue still comes from Chinese pharmaceutical distribution, with 63 customers of which four each exceeded 10% of revenue. Key risks flagged include material weaknesses in internal control over financial reporting, Nasdaq bid-price non-compliance with a second compliance period ending January 4, 2027 and a possible reverse split to cure it, extensive PRC regulatory exposure, and export-control risks for the new AI infrastructure business. The stock traded between $0.2504 and $1.68 over the past year and 34,427,559 shares were outstanding as of September 22, 2026.
Quanome Technologies (Nasdaq: QNME) signed an approximately US$18.8 million purchase agreement on September 16, 2026 for NVIDIA GPU-powered computing infrastructure to build its AI cloud business through subsidiary XDT Infrastructure I, LLC. The company plans a phased build-out of its first U.S. AI infrastructure hub, expected to be operational from Q4 2026, offering managed AI computing capacity and aiming to generate recurring revenue. The press release is furnished under Item 7.01 and carries explicit forward-looking-statement caveats on financing availability, supplier performance, and deployment timing — execution and funding remain key risks.
LSH: 8-K · leadership change
Quanome Technologies' board accepted director Xiaoou Li's resignation effective September 21, 2026, stating the departure was not due to any disagreement with the company on any matter relating to its operations, policies or practices. The same day, the board elected Chao Liu, age 44, as a new independent director to fill the vacancy, keeping the board at five members with a majority independent under the Nasdaq Marketplace Rules. Ms. Liu, who leads Prosperity Alliance Singapore and The HLW Investment entities, joins the Audit, Compensation, and Nominating and Corporate Governance Committees, with compensation consistent with other non-employee directors per the company's January 30, 2026 proxy statement.
Quanome Technologies, Inc. entered into a Purchase and Sale Agreement with Compal Electronics, Inc. on September 16, 2026 to purchase 32 GPU server units for an aggregate price of approximately US$18.8 million. Payment is structured as a 20% initial payment after the purchase order is accepted, with the remaining 80% due before shipment; completion remains subject to financing availability, supplier production and delivery, product registration, and other supply-chain and commercial conditions. The company intends to deploy the servers in its artificial intelligence computing infrastructure business, though the filing cautions there is no assurance the transaction completes on schedule or that the servers are successfully utilized. Note a data-quality issue: the filing cover page lists the Nasdaq trading symbol as QNME, which conflicts with the LSH ticker in the filing metadata.
Quanome Technologies, Inc. (formerly Lakeside Holding Limited) filed Amendment No. 2 to its Form S-3 on September 2, 2026 to register up to $120,000,000 of common stock, preferred stock, debt securities, warrants, rights and units for sale from time to time on a delayed basis. The shelf capacity is roughly five times the company's public float of approximately $23.85 million, although the baby shelf rule caps primary sales at one-third of float per 12 months while float remains below $75 million. Quanome is a Nevada holding company with substantially all operations run through Hupan Pharmaceutical, a PRC distributor of infusion products, foods for special medical purposes and specialty pharmaceuticals. The company exited its American Bear Logistics operations in February 2026 and is evaluating a repositioning toward quantum-enabled artificial intelligence and post-quantum cryptography through Quantum Nexus Technologies, a Cayman subsidiary with no revenue to date. The prospectus discloses a Nasdaq minimum bid price deficiency first noticed January 7, 2026, with a second compliance period running until January 4, 2027 and a possible reverse stock split to cure. With the stock closing at $0.3302 on September 1, 2026, the filing flags material dilution, delisting and PRC regulatory risks, including possible CSRC filing requirements for future takedowns and restrictions on moving cash out of China.
LSH: 8-K · other
Quanome Technologies, Inc. (Nasdaq: QNME), formerly Lakeside Holding Limited, filed an 8-K on August 20, 2026 announcing the formation of its Global Quantum Council and Scientific Advisory Network under Item 7.01 Regulation FD disclosure. The Council is organized around four specialist streams: Quantum Systems, Molecular Discovery, Advanced Nuclear Technologies, and Quantum-Safe Cybersecurity. CEO Yang Li said several subject matter experts have been identified and their involvement is expected to be formalized in the near term as a critical aspect of the company's 2026-and-beyond strategy. No named members, financial terms, or commercial commitments were disclosed. The forward-looking statements section notes the company's need to regain and maintain compliance with Nasdaq continued listing requirements, a detail investors should track alongside the quantum advisory push.
Contrasting Lakeside (NASDAQ:LSH) and PostNL (OTCMKTS:TNTFF)
LSH: 8-K · ticker change
Quanome Technologies, Inc., formerly Lakeside Holding Limited, announced that its common stock began trading on the Nasdaq Capital Market under the new corporate name and updated ticker symbol QNME as of August 5, 2026, replacing the prior LSH symbol. The rebrand accompanies a stated strategic pivot toward quantum computing, artificial intelligence, advanced simulation, and intelligent systems, with initial areas of interest including quantum and AI-enabled decision systems, molecular and materials simulation, and pharmaceutical and healthcare applications. Management also cited NIST's finalized post-quantum cryptography standards as a source of future opportunities in cybersecurity. The furnished press release contains no financial figures, and its forward-looking statements disclose the company must regain and maintain compliance with Nasdaq continued listing requirements, suggesting current listing non-compliance and material execution risk for the pivot.
Quanome Technologies, Inc. (formerly Lakeside Holding Limited) filed Pre-Effective Amendment No. 1 to its Form S-3 shelf registration, covering up to $120,000,000 of common stock, preferred stock, debt securities, warrants, rights, and units to be sold from time to time. The filing also confirms the corporate name change effective August 3, 2026 and the switch to the new Nasdaq ticker QNME, which began trading on August 4, 2026. The shelf sits on a very small base: at the August 4, 2026 close of $0.6928, public float was only about $21.98 million across 31.7 million non-affiliate shares, and the Baby Shelf rule caps primary sales at one-third of float in any 12 months while float stays below $75 million. The stock is also below Nasdaq's $1.00 minimum bid; the company has until January 4, 2027 to regain compliance and has told Nasdaq it may effect a reverse stock split to cure the deficiency. Substantively, the filing describes a company in transition: it divested its U.S. logistics business (American Bear Logistics) in February 2026, now generates revenue from China pharmaceutical distribution through Hupan Pharmaceutical, and is evaluating a pivot into quantum-enabled artificial intelligence and post-quantum cryptography via new Cayman subsidiary Quantum Nexus, an initiative with no revenue and no definitive agreements to date.
Quanome Technologies, Inc., formerly known as Lakeside Holding Limited, changed its corporate name via a Nevada Certificate of Amendment effective 5:00 p.m. Eastern Time on August 3, 2026. Because the amendment was a name-only change under NRS 78.390, no stockholder approval was required and shareholders' rights are unaffected. The company's common stock continues to be listed on The Nasdaq Capital Market, but trades under the new symbol QNME beginning with the open on August 4, 2026, and the CUSIP is unchanged. The Board also adopted Bylaws Amendment No. 1 on August 3, 2026, updating name references throughout the bylaws and implementing stockholder-approved changes from November 25, 2025, including lowering the quorum threshold to one-third of the voting power of outstanding shares.
Lakeside (NASDAQ:LSH) Shares Up 12.6% – Here’s Why
LSH: 8-K · delisting
Lakeside Holding has received an additional 180-day extension from Nasdaq to regain compliance with the minimum $1.00 bid price requirement, pushing the deadline to January 4, 2027. The company failed to cure the deficiency during its initial 180-day period but remains listed after meeting other continued listing standards. To regain compliance, Lakeside stated it may effect a reverse stock split if necessary. The stock must maintain a closing bid price of at least $1.00 for a minimum of 10 consecutive business days during the new compliance period to satisfy Nasdaq. If the company cannot demonstrate compliance by January 4, 2027, its securities will be subject to delisting, though the company may appeal such a determination. Management intends to monitor the bid price and evaluate options to maintain the listing.
LSH: S-3 · shelf registration
Lakeside Holding Limited filed a shelf registration statement on Form S-3 to offer and sell up to $120 million in aggregate principal amount of securities, which may include common stock, preferred stock, debt securities, warrants, rights, and units. The company intends to use any net proceeds for general corporate purposes as detailed in future prospectus supplements. The filing follows a strategic shift in February 2026, during which the company transferred its logistics operations to an unrelated third party to focus exclusively on pharmaceutical distribution in China through its subsidiary, Hupan Pharmaceutical. The company also noted it has formed entities to evaluate potential digital asset business activities, though no concrete operational plan has been adopted. Lakeside remains an emerging growth company and smaller reporting company but faces potential delisting risks. The company received a Nasdaq deficiency notice on January 7, 2026, for failing to maintain the $1.00 minimum bid price, with a compliance deadline of July 7, 2026, and its stock closed at $0.4198 on that date.
LSH: 8-K · amendment
Lakeside Holding Limited filed an amendment to its articles of incorporation on July 2, 2026, significantly increasing its authorized capital stock. The amendment raises the number of authorized common shares from 200 million to 2 billion and adds authorization for 1 billion shares of blank check preferred stock. This amendment was previously approved by shareholders at the annual meeting on February 12, 2026. The authorization of blank check preferred stock grants the board of directors broad discretion to determine voting powers, dividend rates, and conversion privileges without further shareholder approval. As of the filing date, no series of preferred stock has been designated, and no certificates of designation have been filed. The changes are effective immediately, providing the company with substantial flexibility for future capital raising activities.
Lakeside Holding Limited announced the resignation of Henry Liu as Co-Chief Executive Officer, effective June 2, 2026. Yang Li, the remaining Co-CEO, will now serve as the sole Chief Executive Officer of the company. The company stated that Liu’s departure was not the result of any disagreement with the company regarding operations, policies, or practices.
Lakeside (NASDAQ:LSH) and Jungheinrich (OTCMKTS:JGHAF) Critical Analysis
